Joseph T. Schepers
Keine laufenden Positionen mehr
Profil
Joseph T.
Schepers held several positions in investor relations and communications, including Director of Investor Relations at Shionogi Pharma, Director of Investor Relations at Novartis AG, and Executive Director of Investor Relations and Corporate Communications at Chimerix, Inc. He also served as Vice President of Corporate Communications at Artivion, Inc. and Vice President of Investor Relations at Aravive, Inc. Prior to these roles, he was the VP of Corporate Communications and Investor Relations at Bausch Health Americas, Inc. from 2000 to 2003.
Schepers earned an undergraduate degree and an MBA from Seton Hall University.
Ehemalige bekannte Positionen von Joseph T. Schepers
| Unternehmen | Position | Ende |
|---|---|---|
| CHIMERIX, INC. | Investor Relations Kontakt | - |
| PERNIX THERAPEUTICS HOLDINGS INC | Investor Relations Kontakt | 01.01.2013 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Public Communications Contact | 01.01.2003 |
| ARAVIVE, INC. | Investor Relations Kontakt | - |
| NOVARTIS AG | General Counsel | - |
Ausbildung von Joseph T. Schepers
| Seton Hall University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ARTIVION, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| CHIMERIX, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
